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LETTER TO THE EDITOR
'Macrophages' and their putative significance in human breast cancer
Sir - The article by J. Vaage and P. Harlos entitled 'Collagen
production by macrophages in tumour encapsulation and
dormancy' that appeared in this Journal (May 1991, vol 63,
No. 5, pp 758-762) deals with a potentially very important
aspect of tumour biology the close relationship between
macrophages and fibroblasts and their involvement in
tumour growth. Using implants of mammary carcinoma cells
in mice they found evidence that macrophages rather than
fibroblasts were involved in collagen production and en-
capsulation of regressing tumours.
For many years it has been recognised that macrophages
as part of the mononuclear phagocytic system are involved in
tissue repair in wound healing, tissue reshaping in embryo-
logy, removal of tissue debris from necrotic areas, etc. Lately,
other roles have been discovered for these cells. For example,
macrophages can be involved in antigen recognition by T-
lymphocytes, growth factor production and cytotoxicity to
cancer cells by a non-immunological mechanism. In addition
these cells possess the capacity for rapid migration into
various tissues. These characteristics make them ideal can-
didates for acquiring many diverse functions depending on
the specific microenvironment in which they reside at any
given time. This is particularly evident in the transient func-
tions of these cells in the wound healing process (Whalen,
1990).
We have compared the relative macrophage concentration
and the relative cancer growth rate in 25 human breast
cancers. Macrophages were identified using the macrophage
specific Dakopatt CD 68, M814 antibody which is a marker
of an intracytoplasmic molecule probably associated with
lysosomal granules. Tumour growth was identified using the
KI-67 antibody, a marker of a nuclear associated prolifera-
tion antigen. The tumour growth rate was estimated semi-
quantitatively by assessment of the relative concentration of
tumour nuclei that stain specifically for the KI-67 antibody,
compared to tumour nuclei that did not stain in a cross
section of each tumour. On adjacent cross sections, the
macrophage content was also evaluated semiquantitatively,
by estimating the relative concentration of cells that stained
specifically for the CD 68 antibody. The assessments were
made by two observers. A grade scale of absent/low,
moderate and high was used for both macrophage concentra-
tion and tumour growth rate for comparison. This method of
classification is similar to that used by others (Horst &
Horny, 1987).
Table I presents data of this study showing a comparison
between the relative macrophage concentration and relative
tumour growth in 19 oestrogen receptor (ER) postive and six
ER negative breast carcinomas. Five femtomoles/mg of
tumour protein was used as a cutoff point between absence
and presence of ER.
We found that macrophage infiltration was 'moderate/
high' in most cases (n = 21). We also found that they are
predominantly present in the stroma, which is in agreement
with others (Horst & Horny, 1987).
Although the number of cases in our study is still small, a
strong positive association was detected between macrophage
content and tumour growth rate, particularly for ER negative
tumours. We did not detect a high tumour growth rate in
any of the 25 tumours when the macrophage concentration
was in the absent/low category. In normal or benign breast
tissue (n = 3) extensive macrophage infiltration into the extra-
lobular stroma was not seen, however, a significant number
of macrophages were observed in the small amount of int-
ralobular stroma and within ducts and aveoli.
It cannot be excluded at present that high concentrations
of macrophages are present in rapidly growing tumours
solely as a result of specific stimuli by rapidly dividing cells
and that they serve no particular function in tumour cell
growth. We believe however, that the universal presence of
macrophages in this series ofgrowing breast tumours and the
positive relationship between the degree of infiltration and
tumour growth suggests a possible paracrine growth
regulatory function for macrophages in these tumours.
It is known that activated macrophages are able to pro-
duce many growth factors. Some of these are: transforming
growth factors alpha and beta, fibroblast growth factor,
platelet derived growth factor, tumour necrosis factor and
interleukin-l (Madtes et al., 1988; Old, 1990).It is possible
that any of these factors either directly or indirectly, can
influence the growth of solid breast cancer.
Preliminary evidence from in vitro culture of small breast
cancer fragments grown in Medium 199, supplemented with
20% autologous serum suggests an additional function for
these cells, namely, macrophage to fibroblast transformation.
After 3-4 weeks in culture many 'fibroblast like' cells stain
specifically with the Dakopatt CD-68, M 814 macrophage
monoclonal antibody. Two different types of staining pat-
terns have been observed so far: a cluster pattern, in which
cells positive and negative for the macrophage specific
antibody are grouped together within the same colony and a
checkerboard pattern, in which the two types of cells are
completely intermixed. There are several possible reasons
why it appears that macrophage to fibroblast transformation
is taking place under these conditions:
(1) the presence and the similarity of the two cell types
within the same expanding colony;
Table I Relationships between relative macrophage concentration and
relative growth rate in 19 ER positive ( + ve) and six ER negative (-ve)
tumours
Relative macrophage concentration in breast cancer
(n = 25)
Low Moderate High
+ ve -ve + ve -ve + ve -ve
Relative Low 2 0 1 0 3 0
Growth Moderate 0 0 7 0 4 0
Rate High 0 0 1 0 1 6
Fisher's exact test of contingency (Ghent, 1972) revealed that growth rate
was significantly associated with macrophage concentration (P = 0.03).
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(2) the intracellular staining pattern ranging from total
cytoplasmic staining through partial cytoplasmic staining
to complete absence of staining within cells of the same
colony;
(3) the KI-67 staining and mitotic figures have so far only
been found in macrophage positive staining cells.
These observations suggest that under the culture condi-
tions referred to above, some fibroblasts in human breast
tumours may be derived from macrophages. Vaage and Lind-
blat (1990) report that Metchnikoff as early as 1891 proposed
that blood monocytes could become 'fixed connective tissue
cells' at sites of inflammation, but that this idea never gained
acceptance. Considering that macrophages can produce
growth factors, fibroblasts derived from macrophages could
be regarded as potentially 'dangerous fibroblasts' when they
take up permanent residence within complex cell systems.
This is especially true when these 'fibroblasts' are present in
large numbers. In solid tumours, for example, abnormal
stimuli by cancer cells may trigger production of specific
growth factors by stromal cells, mimicking a continuing
wound healing process (Whalen, 1990). Alternatively, the
positive relationship between macrophages and tumour
growth that we have observed raises the possibility that
macrophage to fibroblast transformation may possibly reduce
a stimulatory effect of these cells on tumour growth.
Evidence for a possible transformation of the type des-
cribed here could be derived from the work of Adams et al.
(1988) who showed that fibroblasts from human breast
cancers are different from fibroblasts derived from normal
breast tissue. Fibroblasts from human breast cancers secreted
a growth factor that stimulated the growth of MCF-7 cells in
vitro, but fibroblasts from normal human breast tissue did
not. Presently there is no evidence that such a transformation
process occurs, in vivo.
If these observations are substantiated, new avenues for
breast cancer therapy should be explored. For example,
agents that interfere with macrophage/fibroblast function and
the putative transformation process may offer considerable
clinical benefit for breast cancer patients. Further charac-
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